Papers

2

Total Citations

121

H-Index

2

About

Dr. Thomas Warkus is a surgical researcher whose work sits at the critical intersection of gynecologic oncology and robotic surgery safety. His most impactful contribution is a landmark randomized controlled trial comparing indocyanine green to methylene blue for sentinel lymph node detection in endometrial cancer. This study, cited 84 times, provided pivotal evidence supporting the use of indocyanine green, directly influencing surgical protocols for lymphatic mapping. Beyond improving cancer staging, Dr. Warkus has made foundational contributions to patient safety in minimally invasive surgery. His highly cited analysis of the da Vinci surgical system, drawing from over 1,200 procedures at a single Canadian academic centre, systematically catalogued intraoperative error reports and malfunctions. This work established a crucial framework for understanding and mitigating technical failures in robotic surgery, offering a transparent, data-driven look at system reliability. By bridging the gap between advanced surgical technology and rigorous clinical outcomes, Dr. Warkus has established himself as a key voice in the safe, effective evolution of robotic-assisted gynecologic oncology.

Research Focus

Key Achievements

2
H-Index
2
Papers
121
Total Citations
61
Avg Citations/Paper
🏆 Most Cited Paper
Green versus blue: Randomized controlled trial comparing indocyanine green with methylene blue for sentinel lymph node detection in endometrial cancer
84 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 20
🏛 Institutions: Centre Hospitalier de l’Université de Montréal, Institute for Research in Immunology and Cancer

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago